loadpatents
Patent applications and USPTO patent grants for Sathyanarayanan; Sriram.The latest application filed is for "compositions and methods for the treatment of cancer (anti-icos antibody dosing)".
Patent | Date |
---|---|
Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing) App 20220281978 - Reeves; Jason Windham ;   et al. | 2022-09-08 |
Extracellular Vesicles Targeting T Cells And Uses Thereof App 20220251200 - LEWIS; Nuruddeen D. ;   et al. | 2022-08-11 |
Gene Signatures for Determining ICOS Expression App 20210340256 - Reeves; Jason Windham ;   et al. | 2021-11-04 |
Extracellular Vesicles Comprising Sting-agonist App 20210322327 - JANG; Su Chul ;   et al. | 2021-10-21 |
Antibodies to ICOS App 20210171635 - Sazinsky; Stephen ;   et al. | 2021-06-10 |
Gene signatures for determining ICOS expression Grant 10,968,277 - Reeves , et al. April 6, 2 | 2021-04-06 |
Exosomes For Immuno-oncology And Anti-inflammatory Therapy App 20200407419 - LEWIS; Nuruddeen D. ;   et al. | 2020-12-31 |
Methods And Compositions For Macrophage Polarization App 20200407725 - SATHYANARAYANAN; Sriram ;   et al. | 2020-12-31 |
Exosomes for immuno-oncology and anti-inflammatory therapy Grant 10,723,782 - Lewis , et al. | 2020-07-28 |
Methods of treating conditions with antibodies that bind B7-H4 Grant 10,626,176 - Sathyanarayanan , et al. | 2020-04-21 |
Antibodies to ICOS Grant 10,570,203 - Sazinsky , et al. Feb | 2020-02-25 |
Compositions and Methods for the Treatment of Cancer App 20200024351 - Reeves; Jason Windham ;   et al. | 2020-01-23 |
Exosomes For Immuno-oncology And Anti-inflammatory Therapy App 20190202892 - Lewis; Nuruddeen D. ;   et al. | 2019-07-04 |
Gene Signatures For Determining Icos Expression App 20180371091 - Reeves; Jason Windham ;   et al. | 2018-12-27 |
Antibodies to ICOS App 20180355041 - Sazinsky; Stephen ;   et al. | 2018-12-13 |
Antibodies to ICOS Grant 10,023,635 - Sazinsky , et al. July 17, 2 | 2018-07-17 |
Methods Of Treating Conditions With Antibodies That Bind B7-h4 App 20170334999 - Sathyanarayanan; Sriram ;   et al. | 2017-11-23 |
Antibodies To Icos App 20160304610 - Sazinsky; Stephen ;   et al. | 2016-10-20 |
Antibodies That Inhibit Tim-3:lilrb2 Interactions And Uses Thereof App 20160200815 - FELDMAN; Igor ;   et al. | 2016-07-14 |
Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapy Grant 9,110,082 - Sathyanarayanan , et al. August 18, 2 | 2015-08-18 |
Igf1 Biomarker For Igf1r Inhibitor Therapy App 20150056191 - Sathyanarayanan; Sriram ;   et al. | 2015-02-26 |
Compositions and methods for treating cancer Grant 8,852,590 - Sathyanarayanan , et al. October 7, 2 | 2014-10-07 |
Methods For The Identification And Treatment Of Patients Sensitive To Anti Igf-1r Inhbition Therapy App 20130323232 - Sathyanarayanan; Sriram ;   et al. | 2013-12-05 |
Combination Therapy For Treating Cancer Comprising An Igf-1r Inhibitor And An Akt Inhibitor App 20130287763 - Sathyanarayanan; Sriram ;   et al. | 2013-10-31 |
Antibodies App 20120058112 - Sathyanarayanan; Sriram ;   et al. | 2012-03-08 |
Compositions And Methods For Treating Cancer App 20120027757 - Sathyanarayanan; Sriram ;   et al. | 2012-02-02 |
Methods for identifying compounds which modulate circadian rhythm App 20030059848 - Reppert, Steven M. ;   et al. | 2003-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.